What is the difference between Axonius SaaS Applications vs OpenIAM?

**Axonius SaaS Applications**: SaaS visibility & risk mgmt platform for shadow IT & app governance. built by Axonius. Core capabilities include Shadow application discovery, Unmanaged browser extension detection, OAuth token identification.. **OpenIAM**: OpenIAM offers a unified identity governance platform featuring CIAM, MFA, and PAM integration.. Both serve the Shadow IT Discovery market but differ in approach, feature depth, and target audience.

Is Axonius SaaS Applications a good alternative to OpenIAM?

Axonius SaaS Applications and OpenIAM serve similar Shadow IT Discovery use cases. Key differences: Axonius SaaS Applications is Commercial while OpenIAM is Free. Review the feature comparison above to determine which fits your requirements.

Axonius SaaS Applications vs OpenIAM: 2026 Comparison Guide | CybersecTools

Axonius SaaS Applications vs OpenIAM: Side-by-Side Comparison (2026)

Features, pricing, ratings, and pros & cons — compared head-to-head.

Axonius SaaS Applications is a commercial shadow it discovery tool by Axonius. OpenIAM is a free identity governance and administration tool. Compare features, ratings, integrations, and community reviews side by side to find the best shadow it discovery fit for your security stack.

CST Verdict

Based on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:

OpenIAM

Mid-market organizations building internal developer platforms or modernizing legacy identity infrastructure will find OpenIAM's free tier valuable for piloting identity governance without license friction. The platform bundles CIAM, MFA, and PAM capabilities in a single deployment, which is rare at the free tier and sidesteps the typical vendor compartmentalization. Skip this if you need deep integration with your existing IAM stack or require vendor support SLAs; OpenIAM's community-driven model means you're debugging with forums, not escalation paths.

Data verified May 2026